Tolvaptan (Otsuka)
- PMID: 15503654
Tolvaptan (Otsuka)
Abstract
Otsuka is developing tolvaptan (OPC-41061), an orally active non-peptide vasopressin V2 antagonist, as a diuretic for the potential treatment of congestive heart failure. By November 2003, tolvaptan was undergoing phase III clinical trials.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources